Publication | Closed Access
Overexpression of AR‐regulated lncRNA TMPO‐AS1 correlates with tumor progression and poor prognosis in prostate cancer
72
Citations
22
References
2018
Year
AR-regulated lncRNA TMPO-AS1 functioned as an oncogenic lncRNA in PCa, and may be a potential diagnostic and prognostic biomarker to be used as a therapeutic target for PCa.
| Year | Citations | |
|---|---|---|
Page 1
Page 1